StockData
Tvardi Therapeutics, Inc. logo

Tvardi Therapeutics, Inc. (TVRD) stock

TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.01−0.09 (-8.18%)

Close on Nov 17, 2026Market cap $13.47MP/E –Yield 0.00%

Tvardi Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Tvardi Therapeutics's price to book ratio was 1.5× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.9× to 20.6×, with a median of 7.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.5×+0.1
2025Dec 31, 20251.4×+0.4
2024Jan 31, 20241.1×−0.3
2023Dec 29, 20231.4×−8.0
2022Dec 30, 20229.4×+0.5
2021Dec 31, 20218.8×−7.8
2020Dec 31, 202016.6×+6.0
2019Dec 31, 201910.6×+0.4
2018Dec 31, 201810.3×−1.8
2017Dec 29, 201712.1×+1.5
2016Dec 30, 201610.6×−1.5
2015Dec 31, 201512.1×−0.2
2014Dec 31, 201412.3×–

More Tvardi Therapeutics figures

See a number that looks wrong?